The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 27, 2022
Filed:
May. 13, 2022
Applicant:
Ocular Therapeutix, Inc., Bedford, MA (US);
Inventors:
Charles D. Blizzard, Nashua, NH (US);
Arthur Driscoll, Reading, MA (US);
Rami El-Hayek, Norwood, MA (US);
Michael Goldstein, Cambridge, MA (US);
Joseph Iacona, Somerville, MA (US);
Peter Jarrett, Burlington, MA (US);
Timothy S. Jarrett, Boston, MA (US);
Erica Kahn, Cambridge, MA (US);
Zachary Lattrell, Newburyport, MA (US);
Assignee:
Ocular Therapeutix, Inc., Bedford, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/4439 (2006.01); A61P 27/02 (2006.01); A61K 31/4427 (2006.01); A61K 47/34 (2017.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0051 (2013.01); A61K 9/06 (2013.01); A61K 31/4427 (2013.01); A61K 31/4439 (2013.01); A61K 47/34 (2013.01); A61P 27/02 (2018.01); A61K 9/0019 (2013.01); A61K 45/06 (2013.01);
Abstract
This invention relates to methods of treatment with a sustained release biodegradable ocular implant containing a tyrosine inhibitor dispersed in a hydrogel.
Blizzard, Charles. (2022). Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor (U.S. Patent No. 11534396). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11534396
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile